Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia.
Aptarion Biotech AG
Aptarion Biotech AG
Hospices Civils de Lyon
Wake Forest University Health Sciences
BioAegis Therapeutics Inc.
University Hospital Augsburg
Johannes Gutenberg University Mainz
Mayo Clinic
Duke University
M.D. Anderson Cancer Center
Carebot s.r.o.
Xijing Hospital
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Royal Marsden NHS Foundation Trust
Nantes University Hospital
National Heart, Lung, and Blood Institute (NHLBI)
CHU de Reims
M.D. Anderson Cancer Center
National Cancer Center, Korea
Fudan University
Radboud University Medical Center
St. James's Hospital, Ireland
Universitätsmedizin Mannheim
Instituto Nacional de Cancerologia de Mexico
Memorial Sloan Kettering Cancer Center
Lata Medical Research Foundation, Nagpur
MedImmune LLC
Kaiser Permanente